NCT07542158 2026-04-21
Ultralow Dose PET Imaging of 18F-FDOPA
Nuclear Imaging Institute
Phase 2 Enrolling by invitation
Clinical Trials
12 trialsNCT02104310 2026-04-06
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
Mayo Clinic
Active not recruiting
NCT07025226 2026-01-26
Senolytics
Mayo Clinic
Phase EARLY_PHASE1 Recruiting
NCT01991977 2025-10-20
18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Mayo Clinic
Phase 2 Completed
NCT01165632 2025-09-02
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT03778294 2025-07-03
18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
Mayo Clinic
Phase 2 Completed
NCT02020720 2025-01-23
18F-DOPA-PET in Planning Surgery in Patients With Gliomas
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT05512403 2024-09-19
KING
Central Hospital, Nancy, France
Phase 3 Recruiting
NCT03242824 2023-03-14
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
Mayo Clinic
Phase 2 Completed
NCT02176720 2018-08-17
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
The Methodist Hospital Research Institute
Phase 1 Terminated
NCT02175745 2017-03-20
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
Stanford University
Phase NA Terminated
NCT02371031 2016-11-30
FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
Washington University School of Medicine
Phase 1 Terminated